BNP Paribas Asset Management’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $207M | Buy |
331,560
+58,440
| +21% | +$39.8M | 0.21% | 91 |
|
|
2026
Q1 | $211M | Buy |
273,120
+26,644
| +11% | +$20.4M | 0.24% | 78 |
|
|
2025
Q4 | $190M | Buy |
246,476
+11,644
| +5% | +$7.91M | 0.22% | 86 |
|
|
2025
Q3 | $132M | Sell |
234,832
-205,592
| -47% | -$116M | 0.34% | 57 |
|
|
2025
Q2 | $231M | Sell |
440,424
-91,790
| -17% | -$51.2M | 0.56% | 29 |
|
|
2025
Q1 | $338M | Buy |
532,214
+20,658
| +4% | +$14.2M | 0.91% | 16 |
|
|
2024
Q4 | $364M | Buy |
511,556
+25,709
| +5% | +$21.6M | 0.9% | 15 |
|
|
2024
Q3 | $511M | Sell |
485,847
-14,427
| -3% | -$16.1M | 1.27% | 9 |
|
|
2024
Q2 | $526M | Buy |
500,274
+96,266
| +24% | +$93.3M | 1.36% | 9 |
|
|
2024
Q1 | $389M | Buy |
404,008
+18,788
| +5% | +$17.9M | 1.03% | 11 |
|
|
2023
Q4 | $338M | Buy |
385,220
+202,735
| +111% | +$167M | 0.94% | 15 |
|
|
2023
Q3 | $150M | Buy |
182,485
+66,664
| +58% | +$52.4M | 0.46% | 43 |
|
|
2023
Q2 | $83.2M | Buy |
115,821
+43,259
| +60% | +$33.4M | 0.26% | 96 |
|
|
2023
Q1 | $59.6M | Buy |
72,562
+3,218
| +5% | +$2.43M | 0.21% | 119 |
|
|
2022
Q4 | $50M | Sell |
69,344
-690
| -1% | -$509K | 0.18% | 143 |
|
|
2022
Q3 | $48.2M | Buy |
70,034
+43,926
| +168% | +$27.6M | 0.19% | 125 |
|
|
2022
Q2 | $15.4M | Buy |
26,108
+2,156
| +9% | +$1.4M | 0.06% | 321 |
|
|
2022
Q1 | $16.7M | Buy |
23,952
+7,200
| +43% | +$4.56M | 0.06% | 328 |
|
|
2021
Q4 | $10.6M | Buy |
16,752
+9,281
| +124% | +$5.71M | 0.04% | 435 |
|
|
2021
Q3 | $4.52M | Buy |
7,471
+400
| +6% | +$248K | 0.02% | 565 |
|
|
2021
Q2 | $3.95M | Sell |
7,071
-1,453
| -17% | -$736K | 0.01% | 589 |
|
|
2021
Q1 | $4.03M | Sell |
8,524
-414
| -5% | -$202K | 0.02% | 559 |
|
|
2020
Q4 | $4.32M | Buy |
8,938
+50
| +0.6% | +$27K | 0.02% | 524 |
|
|
2020
Q3 | $4.97M | Buy |
8,888
+4,528
| +104% | +$2.75M | 0.03% | 435 |
|
|
2020
Q2 | $2.72M | Sell |
4,360
-1,196
| -22% | -$679K | 0.02% | 528 |
|
|
2020
Q1 | $2.71M | Buy |
5,556
+2,357
| +74% | +$972K | 0.02% | 508 |
|
|
2019
Q4 | $1.2M | Sell |
3,199
-1,386
| -30% | -$466K | 0.01% | 638 |
|
|
2019
Q3 | $1.27M | Sell |
4,585
-1,299
| -22% | -$384K | 0.01% | 646 |
|
|
2019
Q2 | $1.84M | Buy |
5,884
+3,895
| +196% | +$1.3M | 0.02% | 575 |
|
|
2019
Q1 | $817K | Sell |
1,989
-154
| -7% | -$63.4K | 0.01% | 728 |
|
|
2018
Q4 | $777K | Buy |
2,143
+197
| +10% | +$72.1K | 0.01% | 737 |
|
|
2018
Q3 | $786K | Buy |
1,946
+122
| +7% | +$46.4K | 0.01% | 738 |
|
|
2018
Q2 | $629K | Hold |
1,824
| – | – | 0.01% | 798 |
|
|
2018
Q1 | $628K | Buy |
1,824
+260
| +17% | +$90.4K | 0.01% | 795 |
|
|
2017
Q4 | $588K | Sell |
1,564
-137
| -8% | -$55.5K | 0.01% | 798 |
|
|
2017
Q3 | $761K | Sell |
1,701
-432
| -20% | -$206K | 0.01% | 774 |
|
|
2017
Q2 | $1.05M | Sell |
2,133
-588
| -22% | -$257K | 0.01% | 741 |
|
|
2017
Q1 | $1.05M | Sell |
2,721
-790
| -23% | -$293K | 0.01% | 752 |
|
|
2016
Q4 | $1.29M | Sell |
3,511
-4,622
| -57% | -$1.76M | 0.01% | 730 |
|
|
2016
Q3 | $3.27M | Sell |
8,133
-271
| -3% | -$109K | 0.03% | 608 |
|
|
2016
Q2 | $2.94M | Buy |
8,404
+404
| +5% | +$156K | 0.02% | 612 |
|
|
2016
Q1 | $2.88M | Buy |
8,000
+176
| +2% | +$72.5K | 0.02% | 599 |
|
|
2015
Q4 | $4.25M | Buy |
7,824
+1
| +0% | +$542 | 0.04% | 505 |
|
|
2015
Q3 | $3.64M | Sell |
7,823
-424
| -5% | -$228K | 0.03% | 543 |
|
|
2015
Q2 | $4.21M | Sell |
8,247
-2,774
| -25% | -$1.35M | 0.03% | 541 |
|
|
2015
Q1 | $4.98M | Buy |
11,021
+3,577
| +48% | +$1.52M | 0.04% | 487 |
|
|
2014
Q4 | $3.05M | Buy |
7,444
+2,680
| +56% | +$1.05M | 0.02% | 535 |
|
|
2014
Q3 | $1.72M | Sell |
4,764
-159
| -3% | -$53.3K | 0.01% | 645 |
|
|
2014
Q2 | $1.39M | Sell |
4,923
-3,964
| -45% | -$1.17M | 0.01% | 718 |
|
|
2014
Q1 | $2.67M | Buy |
8,887
+4,041
| +83% | +$1.24M | 0.02% | 578 |
|
|
2013
Q4 | $1.33M | Buy |
4,846
+4,112
| +560% | +$1.18M | 0.01% | 695 |
|
|
2013
Q3 | $230K | Buy |
+734
| New | +$193K | ﹤0.01% | 786 |
|
Other funds holding REGN
BNP Paribas Asset Management's REGN Position: Q2 2026 in Review
BNP Paribas Asset Management increased its Regeneron Pharmaceuticals (REGN) stake by 21% in Q2 2026, buying an estimated $39.8M and bringing the position to 331,560 shares worth $207M. The position accounts for 0.21% of the portfolio, ranked #91.
BNP Paribas Asset Management first reported a position in REGN in Q3 2013 and has held it in 52 quarters since. The position peaked at $526M in Q2 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2026.
- BNP Paribas Asset Management held 331,560 shares of Regeneron Pharmaceuticals worth $207M as of Q2 2026.
- BNP Paribas Asset Management bought 58,440 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $39.8M.
- Regeneron Pharmaceuticals made up 0.21% of BNP Paribas Asset Management's portfolio in Q2 2026, its #91 holding.
- BNP Paribas Asset Management first reported a position in Regeneron Pharmaceuticals in Q3 2013 and has held it in 52 quarters since.
- BNP Paribas Asset Management's Regeneron Pharmaceuticals position peaked at $526M in Q2 2024.
- 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.
Based on BNP Paribas Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.